Evidence map›Paper›PMID 27995898›Full record

ArticleeLife2016

IRBIT controls apoptosis by interacting with the Bcl-2 homolog, Bcl2l10, and by promoting ER-mitochondria contact.

Benjamin Bonneau, Hideaki Ando, Katsuhiro Kawaai, Matsumi Hirose, Hiromi Takahashi-Iwanaga, Katsuhiko Mikoshiba

Open access · goldAbstract read
In one paragraph

Article in eLife, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Balancing ER-Mitochondrial CaTrends in cell biology · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Benjamin BonneauLaboratory for Developmental Neurobiology, RIKEN Brain Science institute, Wako-shi, Japan.ORCID 0000-0003-2302-5369
Hideaki AndoLaboratory for Developmental Neurobiology, RIKEN Brain Science institute, Wako-shi, Japan.
Katsuhiro KawaaiLaboratory for Developmental Neurobiology, RIKEN Brain Science institute, Wako-shi, Japan.
Matsumi HiroseLaboratory for Developmental Neurobiology, RIKEN Brain Science institute, Wako-shi, Japan.
Hiromi Takahashi-IwanagaDepartment of Anatomy, School of Medicine Hokkaido University, Sapporo, Japan.
Katsuhiko MikoshibaLaboratory for Developmental Neurobiology, RIKEN Brain Science institute, Wako-shi, Japan.ORCID 0000-0002-3487-6970
RIKEN Center for Brain Science · JPHokkaido University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IRBIT is a molecule that interacts with the inositol 1,4,5-trisphosphate (IP

Indexed as

ApoptosisAnimalsCell LineEndoplasmic ReticulumHumansInositol 1,4,5-Trisphosphate ReceptorsLectins, C-TypeMembrane ProteinsMiceMitochondriaProtein BindingProtein Interaction MappingProto-Oncogene Proteins c-bcl-2BCL2-like 10 proteinCLECL1 protein, humanInositol 1,4,5-Trisphosphate ReceptorsLectins, C-TypeMembrane ProteinsProto-Oncogene Proteins c-bcl-2apoptosisBcl-2calciumcell biologyIP3Rmitochondria-associated membranesnone

Identifiers

PMID27995898
PMCPMC5173324
OpenAlexW2566175288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.